News | Oncology Diagnostics | April 25, 2018

Interventional pulmonology team viewed the inside of the lungs and obtained a tissue sample with the Auris Health Monarch Platform

El Camino Hospital Performs First U.S. Robotic Lung Cancer Bronchoscopy

April 25, 2018 — The interventional pulmonology team at the Taft Center for Clinical Research at El Camino Hospital in Mountain View, Calif., successfully performed an innovative robotic bronchoscopy procedure to view the inside of the lungs and obtain a tissue sample. This procedure, the first of its kind performed in the United States, took place as part of a clinical trial of Auris Health’s Monarch Platform. Auris recently announced U.S. Food and Drug Administration (FDA) clearance of the platform.

According to the American Cancer Society, lung cancer is the second most common cancer in both men and women. It is often the leading cause of cancer deaths in the United States, having a higher mortality than prostate, colon and breast cancers combined, according to the ACS. Approximately 220,000 people are newly diagnosed with lung cancer each year and more than 155,000 people die from the disease annually in the United States.

The early and accurate diagnosis of lung cancer is critical. Today, 90 percent of people who have lung cancer die from the disease, in part because it is often not found until the cancer is at an advanced stage. As the technology to identify lesions improves and screening for lung cancer in at-risk individuals advances, there will be increased requirements for minimally invasive diagnosis.

The Monarch Platform integrates the latest advancements in robotics, software, data science and endoscopy, with the goal of enabling earlier and more-accurate diagnosis, and eventually treatment, of small and hard-to-reach nodules in the periphery of the lung.

“At El Camino Hospital, we utilize a variety of minimally invasive procedures to visualize internal structures, obtain tissue samples and diagnose lung disease. With the use of the Monarch Platform, we are embarking on a paradigm shift in how we diagnose suspicious nodules in the lung. Since the robotic bronchoscope has the ability to travel deeper into the lung and precisely guide a biopsy instrument to even the most difficult nodules, the technology offers the potential to diagnose lung cancer at an earlier stage,” stated Ganesh Krishna, M.D., medical director of the Interventional Pulmonology Program at El Camino Hospital and fellowship director of the Interventional Pulmonary Fellowship Program in collaboration with University of California, San Francisco (UCSF) and Palo Alto Medical Foundation.

For more information: www.aurishealth.com

 


Related Content

News | FDA

February 12, 2024 — Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) ...

Time February 12, 2024
arrow
News | Artificial Intelligence

February 1, 2024 — Nearly 8,000 veterans are diagnosed with lung cancer each year. Now at-risk veterans will have access ...

Time February 01, 2024
arrow
News | Artificial Intelligence

January 22, 2024 — Thirona, a global company specializing in advanced analysis of thoracic CT images with artificial ...

Time January 22, 2024
arrow
Feature | Artificial Intelligence

Coherent Market Insights has recently published a report, titled, Artificial Intelligence in Oncology Market, By ...

Time January 12, 2024
arrow
News | Artificial Intelligence

January 8, 2024 — Qure.ai, a leading global innovator in medical imaging solutions, has announced its 13th FDA clearance ...

Time January 08, 2024
arrow
News | Radiology Business

December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...

Time December 27, 2023
arrow
News | Radiology Business

December 13, 2023 — The global medical technology company 4DMedical has announced it has entered a binding agreement to ...

Time December 13, 2023
arrow
News | Computed Tomography (CT)

November 28, 2023 — Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs ...

Time November 28, 2023
arrow
News | RSNA

November 25, 2023 — 4DMedical, a global technology company and producer of advanced lung function imaging software, has ...

Time November 24, 2023
arrow
News | Computed Tomography (CT)

November 22, 2023 — Lung cancer is one of the world’s silent killers. By the time patients experience symptoms, the ...

Time November 22, 2023
arrow
Subscribe Now